At the same time, Cheng established a clinical prediction model from 295 NFPA tumor samples and found that three proteins, CDKN2A/p16, WIF1, TGF-β, tumor age and volume, and two clinical features were significantly associated with the recurrence of NFPA (56). This evidence concerns the gene CDKN2A and non-functioning pituitary adenoma.